-
公开(公告)号：EP1675480B1
公开(公告)日：2018-06-13
申请号：EP04790398.4
申请日：2004-10-14
申请人： Nestec S.A.
发明人： SCHIFFRIN, Eduardo , BREUILL , Denis , BLUM-SPERISEN, Stéphanie , DONNET-HUGHES, Anne , FAURE, Magali , ROESSLE, Claudia , TURINI, Marco, Enrico
IPC分类号： A23L33/00 , A23L33/19 , A23L33/175
摘要： The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid form, comprises casein and whey proteins, TGF-beta and free glutamine.
-
公开(公告)号：EP2429570A1
公开(公告)日：2012-03-21
申请号：EP10717651.3
申请日：2010-05-07
申请人： Nestec S.A.
发明人： FAURE, Magali , WANG, Bing , SCHMITT, Jeroen
CPC分类号： A61K38/40 , A23L2/66 , A23L33/19 , A23L33/40 , A23V2002/00 , A61K35/20 , A23V2250/54248 , A23V2200/322 , A23V2200/32
摘要： The present invention relates generally to the field of neuronal health and neuronal protection. One embodiment of the present invention relates to a composition that can be used for the protection of the enteric nervous system from neurodegeneration. Disorders linked to an impaired enteric nervous system can be treated or prevented by the administration of lactoferrin containing compositions according to the present invention.
-
3.发明公开PROMOTION OF HEALING OF INTESTINAL MUCOSA USING PROLINE, SERINE AND THREONINE 审中-公开用脯氨酸，丝氨酸和苏氨酸促进肠粘膜愈合
公开(公告)号：EP3247344A1
公开(公告)日：2017-11-29
申请号：EP16701321.8
申请日：2016-01-22
申请人： Nestec S.A.
发明人： FAURE, Magali , BLUM-SPERISEN, Stéphanie , BOSCO, Mohamed Nabil , BRAHMBHATT, Viral , BREUILLE, Denis
IPC分类号： A61K31/198 , A61P29/00 , A61P19/00
CPC分类号： A61K31/401 , A23L33/175 , A23V2002/00 , A61K31/198
摘要： Methods and compositions are provided that use proline, serine and threonine to promote healing of the intestinal mucosa. A therapeutically effective amount of proline, serine and threonine is administered to an individual in need thereof, for example a human or other mammal, such as an individual that has damaged intestinal mucosa. The methods and compositions can promote mucosal healing, restore gut barrier function, repair intestinal epithelial cells, promote protection of the colonic epithelium, and/or promote the replenishment of goblet cells in the intestinal and colonic mucosa.
-
公开(公告)号：EP3247343A1
公开(公告)日：2017-11-29
申请号：EP16701315.0
申请日：2016-01-22
申请人： Nestec S.A.
IPC分类号： A61K31/198 , A61K31/401 , A61K38/18 , A61K31/70 , A61K31/715 , A61K31/718 , A61K35/20 , A61K31/202 , A61P29/00 , A61K31/20 , A23L2/00
CPC分类号： A61K31/401 , A23L2/00 , A23V2250/064 , A23V2250/0642 , A23V2250/0648 , A23V2250/1868 , A23V2250/28 , A23V2250/50 , A23V2250/54252 , A61K31/198 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/70 , A61K31/715 , A61K31/718 , A61K35/20 , A61K38/1841 , A61K2300/00
摘要： Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
-
公开(公告)号：EP1638418B1
公开(公告)日：2012-08-29
申请号：EP04739936.5
申请日：2004-06-16
申请人： Nestec S.A.
CPC分类号： A61K31/198 , A23K20/142 , A23K20/147 , A23K50/40 , A23L33/175 , A23L33/40 , A23V2002/00 , A61K9/0095 , A61K31/195 , A61K31/401 , A23V2250/0642 , A23V2250/064 , A23V2250/0648 , A23V2250/0616 , A23V2250/0612 , A23V2250/16 , A23V2250/1578 , A23V2250/161 , A23V2250/1612 , A23V2250/1592 , A23V2250/1588 , A23V2250/1642 , A23V2250/06 , A23V2250/156 , A23V2250/702 , A23V2250/704 , A23V2250/641 , A23V2250/0644
摘要： The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favour the growth of bacteria favourable to indivuduals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.
-
6.发明公开LACTOFERRIN AND BRAIN HEALTH AND DEVELOPMENT IN INFANTS 审中-公开联合国儿童基金会联合国儿童基金会（ENTWICKLUNG VONSÄUGLINGEN）
公开(公告)号：EP2429572A1
公开(公告)日：2012-03-21
申请号：EP10718172.9
申请日：2010-05-07
申请人： Nestec S.A.
发明人： WANG, Bing , FAURE, Magali , SCHMITT, Jeroen
摘要： The present invention relates generally to the field of brain development and brain health. One embodiment of the present invention relates to a composition that can be used for the treatment or prevention of a delayed brain development and/or a delayed development of the nervous system. Also cognitive performance can be increased.
摘要翻译： 本发明一般涉及脑发育和脑健康领域。 本发明的一个实施方案涉及可用于治疗或预防脑发育迟缓和/或神经系统延迟发展的组合物。 还可以增加认知能力。
-
7.发明公开
公开(公告)号：EP1675480A1
公开(公告)日：2006-07-05
申请号：EP04790398.4
申请日：2004-10-14
申请人： NESTEC S.A.
发明人： SCHIFFRIN, Eduardo , BREUILL , Denis , BLUM-SPERISEN, Stéphanie , DONNET-HUGHES, Anne , FAURE, Magali , ROESSLE, Claudia , TURINI, Marco, Enrico
摘要： The present invention relates to a nutritional composition suitable for patients undergoing chemotherapy and/or radiation such as cancer patients. The composition, which may be in powder or liquid form, comprises casein and whey proteins, TGF-beta and free glutamine.
摘要翻译： 本发明涉及一种适合于进行化疗的患者和/或辐射的营养组合物：如癌症的患者。 所述的组合物，其可以是粉末或液体形式，包括酪蛋白和乳清蛋白，TGF-β和游离谷氨酰胺。
-
公开(公告)号：EP3079485B1
公开(公告)日：2019-05-01
申请号：EP14811887.0
申请日：2014-12-12
申请人： Nestec S.A.
发明人： FAURE, Magali
-
公开(公告)号：EP3082455B1
公开(公告)日：2018-08-08
申请号：EP14820785.5
申请日：2014-12-12
申请人： Nestec S.A.
发明人： FAURE, Magali
IPC分类号： A23L3/3454
CPC分类号： A61K35/20 , A23L33/19 , A23L33/40 , A23V2002/00 , A61K35/745 , A61K35/747 , A61K2300/00 , A23V2200/322 , A23V2250/54252
摘要： The present invention relates to administration of sweet whey protein (SWP) for promoting the enteric neuronal development in infants, especially preterm, low birth, very low and extremely low birth weight infants as well as in young children up until the age of six. Administration of the SWP according to the invention prevents and treats disorders associated with an immature or impaired enteric nervous system. The disorders are, notably, dysfunctional gastrointestinal motility manifested as slow intestinal transit, intestinal discomfort, hard stools, constipation and/or gastrointestinal reflux, gut barrier dysfunction, food intolerance or necrotizing enterocolitis.
-
公开(公告)号：EP3247345A1
公开(公告)日：2017-11-29
申请号：EP16702355.5
申请日：2016-01-22
申请人： Nestec S.A.
发明人： FAURE, Magali , BLUM-SPERISEN, Stéphanie , BOSCO, Mohamed Nabil , BRAHMBHATT, Viral , BREUILLE, Denis
IPC分类号： A61K31/198 , A61P29/00 , A61P19/02
CPC分类号： A61K31/198 , A61K45/06 , Y02A50/465
摘要： Methods and compositions are provided that treat or prevent inflammation using serine. A therapeutically effective amount of serine is administered to an individual, for example a human or other mammal, that has inflammation or is at risk of inflammation. The methods and compositions can control and/or alleviate an inflammatory reaction of the body, such as colitis.
-
-
-
-
-
-
-
-
-
搜索结果
25 条记录 (耗时 0.012 秒)
